SCHEMBL6852991

SCHEMBL6852991

C1=Cc2cccc3c2N(C1)Cc1cnccc1-3

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6228672 0.66
SCHEMBL6089366 0.64 PARP1 (0.35)
SCHEMBL2174440 0.63 HTR2C (0.43) MAOAMAOB
SCHEMBL28547192 0.63
SCHEMBL3333311 0.61 HTR2C (0.46)
SCHEMBL9129097 0.61
SCHEMBL30322772 0.60 MAOA (0.47) MAOAMAOB
SCHEMBL2239784 0.60 MAOA (0.47) MAOAMAOB
SCHEMBL14452876 0.60 SIGMAR1 (0.48) PDE3BPDE3AMAOAMAOB
SCHEMBL29699898 0.60 SIGMAR1 (0.48) PDE3BPDE3AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6777406-B2 SUCH AS PYRIDO(3,2,1-IJ)PYRROLO(3,4-C)QUINOLIN-8-ONE DERI-VATIVES; CENTRAL NERVOUS SYSTEM DISORDERS; GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-17 US disclosed